Latest News

Current interest rate trends and turnaround uncertainty call into question buying Nike for its relatively high forward dividend yield.

Regional banking company Valley National Bancorp (NASDAQ:VLY) reported Q3 2026 results beating Wall Street’s revenue expectations, with sales up 14% year on ...

Short answer: Higher rates hurt some AI companies a lot more than others.

Commercial real estate firm CBRE (NYSE:CBRE) missed Wall Street’s revenue expectations in Q3 2026, but sales rose 12.7% year on year to $11.52 billion. Its n...

Starbucks may finally be turning the corner after years of lackluster returns.

Commercial rental vehicle and delivery company Ryder (NYSE:R) beat Wall Street’s revenue expectations in Q3 2026, with sales up 8.3% year on year to $3.43 bi...

Global exchange operator Nasdaq (NASDAQ:NDAQ) reported Q3 2026 results beating Wall Street’s revenue expectations, with sales up 14.1% year on year to $1.5 b...

Bristol Myers Squibb has led in seven of eight quarters, but Novo Nordisk's recent spike signals a shift worth watching for income-focused investors.

RTX and Northrop Grumman posted record Q3 backlogs, raised guidance, and strengthened balance sheets, pointing to long-term growth despite margin pressures and paused buybacks.

History says that investors should be prepared for subpar stock market returns.

Manufacturing company Dover (NYSE:DOV) reported Q3 2026 results beating Wall Street’s revenue expectations, with sales up 7.5% year on year to $2.23 billion....

Coconut water company The Vita Coco Company (NASDAQ:COCO) reported Q3 2026 results beating Wall Street’s revenue expectations, with sales up 33.7% year on ye...

Telecommunications and media company Comcast (NASDAQ:CMCSA) met Wall Street’s revenue expectations in Q3 2026, but sales were flat year on year at $29.3 bill...

Eli Lilly's revenue nearly doubled over two years while Bristol Myers Squibb remained relatively flat, widening the gap between these two pharma giants.

Consumer products behemoth Procter & Gamble (NYSE:PG) announced better-than-expected revenue in calendar Q3 2026 (fiscal Q1 2027), with sales up 4% year on y...

Healthcare diagnostics company Quest Diagnostics (NYSE:DGX) reported revenue ahead of Wall Street’s expectations in Q3 2026, with sales up 10% year on year t...

Rural goods retailer Tractor Supply (NASDAQ:TSCO) reported revenue ahead of Wall Street’s expectations in Q3 2026, with sales up 5.1% year on year to $3.91 b...

Automotive technology company Visteon (NYSE:VC) reported Q3 2026 results exceeding the market’s revenue expectations, with sales up 5.8% year on year to $970...

ExxonMobil and Cameco stock have gone in different directions this year. Here's why Cameco may be worth a look.

Security and Aerospace company Lockheed Martin (NYSE:LMT) reported Q3 2026 results topping the market’s revenue expectations, with sales up 11.3% year on yea...

4D Molecular Therapeutics (NASDAQ:FDMT) used its first Investor Day to outline its development and commercial plans for 4D-150, an investigational intravitreal gene therapy for wet age-related macular degeneration, or wet AMD. Company executives and retina specialists described the therapy as a pote

Rentokil Initial (NYSE:RTO) reported third-quarter revenue of $1.9 billion and organic growth of 3.4%, with Chief Executive Officer Mike Duffy describing the period as a “solid quarter” marked by progress on customer service, sales execution and business simplification. North America generated 3.2%

Pearson (NYSE:PSO) said third-quarter sales growth accelerated to 6%, supporting its full-year 2026 outlook as the education company announced a restructuring into four customer-led business units and narrowed its adjusted operating profit range. Chief Executive Officer Omar Abbosh said the company

Professional tools and equipment manufacturer Snap-on (NYSE:SNA) fell short of the market’s revenue expectations in Q3 2026, with sales flat year on year at ...

These stocks all trade at share prices that could make a split attractive.